Antisoma (LSE: ASM.L - news) shares could double if the ovarian cancer drug, R1549, is successful, and halve if it is not says the Independent. Given the probability of success, reckoned to be about 65%, that looks a gamble worth taking says the paper.

Do anyone know the cancer drug going on? share rise a bit today. Is it the prediction of the result is good?

narrow loss....

Loads of sells today and hardly any buys yet the price remains - what is afoot

thinking of buying in as it is nearing the bottom of the present cycle, anyone heard any rumours on the drug testing?

sod it, spent hubby's money anyway, lets hope the tests go well or I'll have to explain the dent in the savings account.

Anyone know why this rise has occured?

it tipped by IC recently

Antisoma (LSE: ASM) has developed a couple of drugs that treat cancer by choking off the supply of blood to tumours. Its AS1404 is expected to move into Phase II trials this year, and the company reckons that the drug has potential against a wide variety of cancers. Antisoma has also started first trials of its AS1405 in patients with a highly malignant brain cancer called glioma. However, the company is not expected to be profitable for at least the next two years.

i think ASM is similar to AZM at some point, drug share, AZM has make a miracle from 50p to now 1.60 so hopefully ASM will do the same.

a red day today.

Dont let it hurt Add I just did at 19p Roche is still firmly behind them.

""The outcome of this study will have no impact on our growth outlook and we
remain committed to our long-term relationship with Antisoma, which is based
upon multiple products,"" William Burns, Head of Roche''s Pharmaceuticals Division said.
""Drug development is a high-risk endeavour and such results are not
unexpected in the development of novel treatment modalities,"" he added.

Last year it halved on bad news, it was tipped to double if the news was good.
What will happen this year if good news flows from next stages of the drug developments. I am tempted to risk a bit on this on, anyone else hold ASM and have any thoughts?

andysmith
I hold asm and I have been adding while the price has been low this share will creep back up to were it was before a nice stock to add to when you feel like it.

I also hold seo as you do (Great minds A).

driver,
was tempted by ASM last year but didn't have enough funds, good job really!!
Releasing some profit soon and got a feeling that ASM worth a punt from here.
Hope it doesn't take-off before I'm in . Also hold MMG in similar field.
As we both have SEO, I will soon have ASM, worth you take a look at MDW, I'm up already and it has yet to fly!! These three could give us a fantastic 2005 with the POTENTIAL, here's hoping!!

Still creeping up, worth looking at if you`re not in already. Is 25p on the horizon for next couple of weeks? Looking strong at the moment.

dandu71
Its going up faster than the trains I drive, 25p easy.

Thanks driver, looking good matey.

Looking even better.

Can't believe it, then again!!
Couldn't decide what to do on Monday and thought there might be a pull back below 20p. There was briefly yesterday but I was out. Didn't get time this morning and suddenly got to pay 22.5p. Now deciding what to do, Would they have paid 11.2m for a company if it looked like the drug would bomb out? It would be very stupid to pay that on a hope. What stage is the Aptomera drug at? Still think I will get in or I know I'll kick myself, just trying to second guess whether now or will there be a drop back and better buying opportunity.

andysmith

Dont know about a drop back a lot of these drug companies slowly pull back after a drug fails to deliver and the next drug comes up from behind and dont forget they still have Roche behind them and a small yearly cash burn with plenty in the bank.